Press Releases about Horizon Therapeutics
![](https://mms.businesswire.com/media/20230414005099/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230414005015/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230410005144/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230404005728/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230316005556/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
March 16, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230314005537/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230310005395/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230301005759/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Horizon Therapeutics plc - Rule 2.12 Announcement
March 01, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230227005744/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230228005315/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230224005319/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230223005284/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230130005183/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230127005311/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 15 (c) Announcement – Horizon Therapeutics plc
January 27, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230125005712/en/1115287/22/Latest_KSF_M%26A.jpg)
![](https://mms.businesswire.com/media/20230123005773/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 17 (b) Announcement – Horizon Therapeutics plc
January 23, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230123005772/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 17 (a) Announcement – Horizon Therapeutics plc
January 23, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230118005359/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230112005852/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 2.12 Announcement – Horizon Therapeutics plc
January 12, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230106005332/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
January 06, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230104005723/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
January 04, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230104005351/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20230103005630/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
January 03, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20221220005190/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221213006106/en/1115287/22/Latest_KSF_M%26A.jpg)
![](https://mms.businesswire.com/media/20221213005736/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Form 8.1 Opening Position Disclosure (Horizon Therapeutics plc)
December 13, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221212005590/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://mms.businesswire.com/media/20221211005090/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc
December 12, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221208005242/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.